Intuitive Surgical (ISRG) Cash from Financing Activities (2009 - 2026)
Intuitive Surgical's (ISRG) quarterly Cash from Financing Activities came in at -$287.9 million in Q2 2026, down 94.79% year-on-year from -$5.5 billion in Q2 2025, and up 78.73% quarter-over-quarter from -$1.4 billion in Q1 2026.
Intuitive Surgical (ISRG) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Intuitive Surgical's Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$287.9 million for Q2 2026.
- On a quarterly basis, Cash from Financing Activities fell 94.79% year-over-year to -$287.9 million in Q2 2026; TTM through Jun 2026 was -$3.6 billion, a 1434.79% decrease from a year earlier, with the FY2025 full-year figure at -$2.4 billion, down 1666.67% from the prior year.
- Cash from Financing Activities grew to -$287.9 million in Q2 2026 per ISRG's latest filing, from -$1.4 billion in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $98.2 million in Q3 2024 and bottomed at -$1.8 billion in Q3 2025.
- The 5-year median for Cash from Financing Activities is -$173.8 million (2022), against an average of -$373.0 million.
- Across the five-year window, Cash from Financing Activities sank 5280.11% in 2022 and soared 256.83% in 2024, its largest moves.
- Year by year, Cash from Financing Activities stood at -$963.5 million in 2022, then jumped by 96.73% to -$31.5 million in 2023, then surged by 256.83% to $49.4 million in 2024, then tumbled by 378.34% to -$137.5 million in 2025, then slumped by 109.38% to -$287.9 million in 2026.
- Per Business Quant, the three latest ISRG Cash from Financing Activities figures stand at -$287.9 million (Q2 2026), -$1.4 billion (Q1 2026), and -$137.5 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | -11.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -287.90 Mn |
| Jun 30, 2026 | -287.90 Mn |
| Mar 31, 2026 | -1.35 Bn |
| Mar 31, 2026 | -1.35 Bn |
| Dec 31, 2025 | -137.50 Mn |
| Dec 31, 2025 | -137.50 Mn |
| Sep 30, 2025 | -1.84 Bn |
| Sep 30, 2025 | -1.84 Bn |
| Jun 30, 2025 | -147.80 Mn |
| Jun 30, 2025 | -147.80 Mn |
| Mar 31, 2025 | -235.80 Mn |
| Mar 31, 2025 | -235.80 Mn |
| Dec 31, 2024 | 49.40 Mn |
| Dec 31, 2024 | 49.40 Mn |
| Sep 30, 2024 | 98.20 Mn |
| Sep 30, 2024 | 98.20 Mn |
| Jun 30, 2024 | 50.00 Mn |
| Jun 30, 2024 | 50.00 Mn |
| Mar 31, 2024 | -46.70 Mn |
| Mar 31, 2024 | -46.70 Mn |